HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma

NCT05290220 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: HLX07
DRUG: HLX10
DRUG: HLX04
DRUG: lenvatinib

Sponsor

Shanghai Henlius Biotech